FOUNDATION LEADERSHIP

President
Mahesh K. Shetty MD;FRCR;FACR;FAIUM
Clinical Professor
Baylor College of Medicine
Medical Director
Woman's Clinic for Breast
and Gynecological Imaging & Pink Door Imaging Center

Patron
Dr Kiran Mazumdar-Shaw
Chairman & Managing Director
Biocon Limited
Bangalore, India

Board of Trustees
Ron Somers
President
US-India Business Council
Washington D.C.

Jennifer Garza
CEO Edinburg Regional Medical Center/Edinburg Children's Hospital
Edinburg, Texas

Mrs. Mona Parikh PHR, MBA
Sr. Human Resources Business
Partner

Mr Andrew Novarini
CEO, Cypress Station Branch
Bank of Houston

Kelli Cohen MD
General and Pediatric Radiologist

Eric S. Greisel J.D.
General Legal Counsel


PROGRAM ADVISOR

Loretta A. Hanser
Director of Imaging Services
Mammography, CHP Radiology
Harris County Hospital District

Regional Directors
Mrs. Trishna Dey [Asia]
Ms. Esther Biira [Africa]
Dr Adhmer Longatto [S.America]
------------------------------


MEDICAL ADVISORY COUNCIL

Chair
Mahesh Shetty MD;FRCR;FACR;FAIUM
Clinical Professor of Radiology
Baylor College of Medicine

Members
Dr. Steve Sener
Former President
American Cancer Society

R. Sankaranarayanan
Chief of Cancer Screening Group
International Agency for Research on Cancer,
WHO
Lyon, France

Saraswati Sukumar MD
Barbara B.Rubenstein Professor of Oncology
Johns Hopkins University School of Medicine

Britt-Marie Ljung, MD
Professor of Clinical Pathology,
Director of Cytopathology
UCSF, California

Dr Usha Menon MD; FRCOG
Professor and Director
Gynecological Cancer Research Center
UCL Elizabeth Garrett Institute of Women's Health
University College London

Dr Edmundo Mauad
Director
Barretos Cancer Hospital,
Sao Paulo, Brazil

Peter Dempsey MD; FACR
Professor of Radiology
MD Anderson Cancer Center

Terri Pustilnik MD
Gynecology Oncology of Houston

Dr Diljeet K. Singh, MD, DrPH
Co Chair of MAC

Dr Wei Yang, M.B.B.S., F.R.C.R.
Professor
Deputy Chairman, Department of Diagnostic Radiology
The University of Texas, M.D. Anderson Cancer Center
Co-Chair and Director of Clinical Research

Dr Neerja Bhatla MD, FICOG
A/Professor, Dept of Ob-Gyn, All India Institute of Medical Sciences, New Delhi, India,
Vice President, AOGIN,
Inaugural President, AOGIN-India,
Organising Chairperson, AOGIN 2010

Dr Jill Donnelly
Consultant Breast Surgeon
Herford Hospital, UK

Dr Martin M. Matzuk M.D., Ph.D.
Stuart A. Wallace Chair
Professor of Pathology and Immunology

------------------------------

PUBLIC AWARENESS COUNCIL

Mrs. Susan Rafte
Chair of the PAC

Mrs. Sathya Saran
Co-chair,
Editor DNA,
Former Editor, Femina,
Mumbai, India

Ms. Lucy Noland
Co-chair,
News Anchor,
KNBC,
Los Angeles

Sharda Cherwoo
Partner
Ernst & Young

 



Dina R. Mody, M.D.
 
Dina R. Mody, M.D.
Senior Member
The Methodist Hospital Research Institute
Director of Cytopathology, Laboratory and Fellowship
The Methodist Hospital
Professor of Pathology and Laboratory Medicine
Weill Medical College of Cornell University
E-MAIL biiraea@yahoo.com
Phone: 713-441-6483
Fax: 713-793-1603
 
Education
M.D. Bombay University, Bombay, India
 
Postdoctoral Training
Rotating Internship, KEM Hospital, Bombay, India
Pathology Residency, Baylor College of Medicine, Houston, TX
 
Biography
After completing her postdoctoral training, Dr. Mody joined the faculty at the Baylor College of Medicine in Houston, Texas as an Instructor of Pathology in 1984. She received her full professorship there in 2000, and held the Ibrahim Ramzy Endowed Chair. Dr. Mody is currently President elect of the American Society of Cytopathology (ASC). She has given numerous workshops, teleconferences, symposia and lectures at its national meetings. She has served on the Executive Board, the Scientific Program Committee and chaired the Quality Assurance Committee. She co-chaired the Practice Guidelines Committee, which developed the Cervical Cytology Practice Guidelines for which she received the President's Award of the ASC in 1999. In 2002, she received the Lansky Award of the College of American Pathologists (CAP) for her leadership role in cytology, and has served as Chair of the CAP Cytopathology Resource Committee. In 2004, Dr. Mody was appointed to the Clinical Laboratory Improvement Advisory Committee (CLIAC) of the CDC, where she serves as an advisor on cytology issues to the CDC and CMS. Previous leadership positions include President of the Texas Society of Cytology, and Chair of Scientific Program of the Houston Society of Clinical Pathologists.
 
Description of Research
Dr. Mody's previous research interests have been in the area of glandular lesions in cervicovaginal cytology and pathology, as well as bone and soft tissue cytology and pathology. Her early papers on tissue and bone reactions to implants were instrumental to the defense when reactions to breast implants were the subject of major litigation in the United States. Dr. Mody's current research focuses on the application of HPV testing and genotyping in low and high risk populations, application of new imaging modalities to diagnostic cytopathology, and immunohistochemical and molecular testing in body fluid cytology.
 
Major Areas of Research
Bone cytology, soft tissue cytology, pathology, HPV, genotyping
 
Recent Publications
Halloush RA, Akpolat I, Jim Zhai Q, Schwartz MR, Mody DR. Comparison of ProEx C with p16INK4a and Ki-67 immunohistochemical staining of cell blocks prepared from residual liquid-based cervicovaginal material: a pilot study.Cancer. 2008 Dec 25;114(6):474-80.

Steinman S, Smith D, Chandler N, Dhurandhar B, Di Filippo L, Scheiber-Pact M, Mody DR. Morphologic, patient and interpreter profiles of high-risk human papillomavirus-positive vs.-negative cases of atypical squamous cells of undetermined significance. Acta Cytol. 2008 May-Jun;52(3):279-85.

Lyons-Boudreaux V, Mody DR, Zhai J, Coffey D. Cytologic malignancy versus benignancy: how useful are the "newer" markers in body fluid cytology? Arch Pathol Lab Med. 2008 Jan;132(1):23-8.

Renshaw AA, Mody DR, Walsh M, Bentz JS, Colgan TJ; Cytopathology Resource Committee, College of American Pathologists. The significance of certification in liquid-based cytology and performance in the college of american pathologists interlaboratory comparison program in cervicovaginal cytopathology. Arch Pathol Lab Med. 2006 Sep;130(9):1269-72.

Renshaw AA, Walsh MK, Blond B, Moriarty AT, Mody DR, Colgan TJ; Cytopathology Resource Committee, College of American Pathologists. Robustness of validation criteria in the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology. Arch Pathol Lab Med. 2006 Aug;130(8):1119-22.
 
 
Woman’s Cancer Foundation
713-428-8590 | 2424 West Holcombe Blvd,102 | Houston, TX 77030

Home | About Us | Every Woman Counts | How Can You Help | Contact Us